Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Jornay pm patent expiration?Entresto competitors?Heparin patent application?Remeron soltab price?Januvia 100 mg tablet price?
See the DrugPatentWatch profile for tinidazole
I can’t determine what you mean by “Nct04512345 tinidazole 505 b 2” from the information provided. NCT04512345 looks like a ClinicalTrials.gov identifier, and “505(b)(2)” refers to the FDA’s abbreviated new drug application pathway. To give you an accurate answer, please paste one of the following: - the full drug/trial title (or a link) tied to NCT04512345, or - what you want to know specifically (for example: trial status/results, who sponsors it, what condition it studies, or whether a tinidazole 505(b)(2) product exists and the regulatory pathway/timeline). If you share the trial’s title/URL, I can summarize the trial and connect it to any available 505(b)(2) regulatory information.
Other Questions About Tinidazole :